White label ELPA - ClinicalTrials.eu

Study Comparing ARV-471 and Palbociclib with Letrozole and Palbociclib for Patients with Estrogen Receptor Positive, HER2-Negative Advanced Breast Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
- (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
- Palbociclib
Study Comparing Tacrolimus Formulations for Preventing Kidney Transplant Rejection in Adults

Not recruiting

3 1 1 1
Investigated drugs:
- Tacrolimus
Study on Gremubamab for Patients with Bronchiectasis and Chronic Pseudomonas Aeruginosa Infection

Not recruiting

2 1
Investigated diseases:
- Pulmonary tuberculosis
- Bronchiectasis
Investigated drugs:
- Gremubamab
Study on the Effectiveness and Safety of Iptacopan for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) Switching from Anti-C5 Antibody Treatment

Not recruiting

3 1 1
Investigated diseases:
- Paroxysmal nocturnal haemoglobinuria
Investigated drugs:
- Iptacopan
Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Not recruiting

3 1
Investigated diseases:
Study on the Safety and Effects of Fenfluramine in Infants Aged 1 to Less Than 2 Years with Dravet Syndrome

Not recruiting

3 1 1 1
Investigated diseases:
- Severe myoclonic epilepsy of infancy
Investigated drugs:
- Fenfluramine Hydrochloride
Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

Not recruiting

3 1 1
Investigated drugs:
+12
Study on Rituximab and Drug Combination for Treating Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

Not recruiting

3 1 1 1
Investigated drugs:
+1
Study of Belzutifan for Patients with Advanced Kidney Cancer

Not recruiting

2 1 1
Investigated diseases:
- Clear cell renal cell carcinoma
Investigated drugs:
- Belzutifan
Study of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis

Not recruiting

3 1 1 1
Investigated diseases:
- Systemic scleroderma
Investigated drugs:
- Anifrolumab
+4

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies